Aly Nada
Impact in
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Discovery top 10%
Papers in
-
- Drug Solubulity and Delivery Systems 17
- Advanced Drug Delivery Systems 11
- Advancements in Transdermal Drug Delivery 5
-
- Pharmacology and Obesity Treatment 5
- Co-authors
- Abdel‐Azim Zaghloul (10 shared papers)Roland Bodmeier (1 shared paper)Ibrahim Khattab (7 shared papers)Ragwa M. Farid (3 shared papers)M. Etman (6 shared papers)Yellela S.R. Krishnaiah (3 shared papers)Emad Eldin Hassan (1 shared paper)Mohsen A. Hedaya (2 shared papers)
- Journals
- International Journal of Pharmaceutics (5 papers)Journal of Microencapsulation (3 papers)Acta Pharmaceutica (2 papers)Journal of Hepatology (2 papers)Current Drug Delivery (1 paper)
- Partner nations
- KuwaitEgyptUnited States
In The Last Decade
Aly Nada
34 papers receiving 358 citations
Peers
Comparison fields: 5 of 83
- Pharmaceutical Science 238
- Drug Discovery 2
- Analytical Chemistry 39
- Molecular Medicine 12
- Biomaterials 33
Countries citing papers authored by Aly Nada
This map shows the geographic impact of Aly Nada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aly Nada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aly Nada more than expected).
Fields of papers citing papers by Aly Nada
This network shows the impact of papers produced by Aly Nada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aly Nada. The network helps show where Aly Nada may publish in the future.
Co-authors
The 25 scholars most cited alongside Aly Nada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 69 | |
| 2 | 2013 | 50 | |
| 3 | 2020 | 24 | |
| 4 | 2019 | 21 | |
| 5 | 2010 | 19 | |
| 6 | 1992 | 18 | |
| 7 | 1995 | 18 | |
| 8 | Hydrotropic and cosolvent solubilisation of indomethacin | 1999 | 16 |
| 9 | 2008 | 13 | |
| 10 | 2014 | 11 | |
| 11 | 2021 | 10 | |
| 12 | Analysis of vitamin E in commercial cosmetic preparations by HPLC. | 2010 | 10 |
| 13 | 2011 | 9 | |
| 14 | 1998 | 9 | |
| 15 | 2017 | 8 | |
| 16 | 2011 | 8 | |
| 17 | 2011 | 8 | |
| 18 | 1993 | 8 | |
| 19 | 2019 | 6 | |
| 20 | 2018 | 5 |
About Aly Nada
Aly Nada is a scholar working on Pharmaceutical Science, Pharmacology, Organic Chemistry, Analytical Chemistry and Materials Chemistry, having authored 36 papers that have together received 389 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (17 papers), Advanced Drug Delivery Systems (11 papers), Pharmacology and Obesity Treatment (5 papers), Advancements in Transdermal Drug Delivery (5 papers), Analytical Methods in Pharmaceuticals (4 papers), Crystallization and Solubility Studies (4 papers), Surfactants and Colloidal Systems (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Pharmaceutical Science (238 citations), Drug Discovery (2 citations), Analytical Chemistry (39 citations), Molecular Medicine (12 citations) and Biomaterials (33 citations). Aly Nada has collaborated with scholars based in Kuwait, Egypt and United States. Frequent co-authors include Abdel‐Azim Zaghloul, Roland Bodmeier, Ibrahim Khattab, Ragwa M. Farid, M. Etman, Yellela S.R. Krishnaiah, Emad Eldin Hassan, Mohsen A. Hedaya, Farzana Bandarkar and Eva-Maria Graf. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Microencapsulation, Acta Pharmaceutica, Journal of Hepatology and Current Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.